Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2026)
Top medical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Industry: Medical Instruments & Sup...

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Medical is Zen Rated B and is the 34th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
NEPH	NEPHROS INC	$4.49	-4.06%	-9.11%	-8.92%	-17.16%	24.72%	172.12%	240.15%	-47.49%	42.54%	$6.42	$1.39	30.06%	223.02%	0.61	40,000	4.17%
INFU	INFUSYSTEM HOLDINGS INC	$8.65	2.00%	2.98%	-3.46%	-13.59%	46.61%	4.59%	-12.09%	-50.82%	200.35%	$11.04	$4.61	21.65%	87.64%	0.90	158,000	50.48%
NVST	ENVISTA HOLDINGS CORP	$24.05	0.88%	-1.19%	9.37%	18.18%	15.96%	11.34%	-36.44%	-34.45%	N/A	$25.41	$14.22	5.33%	69.13%	1.03	1,484,000	-15.39%
KRMD	KORU MEDICAL SYSTEMS INC	$5.63	0.36%	0.90%	-9.63%	36.32%	65.10%	35.66%	42.89%	30.02%	1,224.71%	$6.61	$1.86	14.80%	202.69%	0.95	65,000	-26.14%
EMBC	EMBECTA CORP	$10.74	-1.83%	-12.61%	-10.57%	-23.67%	-5.21%	-44.64%	-60.04%	N/A	N/A	$19.62	$9.20	45.26%	16.74%	0.94	1,034,000	96.58%
MMSI	MERIT MEDICAL SYSTEMS INC	$82.54	1.08%	1.03%	-5.55%	-0.25%	-2.27%	-22.01%	18.73%	39.24%	390.73%	$111.45	$78.12	25.94%	5.66%	0.87	372,000	-37.37%
HBIO	HARVARD BIOSCIENCE INC	$0.58	-2.87%	-1.20%	-18.09%	43.03%	8.70%	-68.06%	-79.97%	-87.55%	-79.32%	$1.83	$0.28	68.58%	104.63%	1.39	220,000	16.40%
ATRC	ATRICURE INC	$38.51	-1.43%	0.23%	-4.51%	5.59%	15.92%	-5.71%	-10.75%	-34.17%	113.47%	$43.18	$28.29	10.82%	36.13%	1.21	442,000	17.55%
AZTA	AZENTA INC	$39.85	-0.50%	0.84%	14.68%	25.00%	16.76%	-26.87%	-29.34%	-48.25%	328.49%	$55.64	$23.91	28.37%	66.67%	1.56	604,000	6.90%
BLCO	BAUSCH & LOMB CORP	$16.87	-0.65%	-1.29%	-1.80%	9.76%	16.83%	-3.32%	-1.52%	N/A	N/A	$18.14	$10.45	7.00%	61.44%	1.08	142,000	-67.51%
ISRG	INTUITIVE SURGICAL INC	$528.81	0.92%	0.26%	-8.48%	-4.07%	7.06%	-7.79%	111.06%	106.12%	772.88%	$609.08	$425.00	13.18%	24.43%	1.29	2,565,000	-7.23%
WST	WEST PHARMACEUTICAL SERVICES INC	$241.40	2.00%	-3.63%	-11.99%	-15.95%	-6.35%	-30.04%	-10.62%	-19.45%	321.51%	$348.90	$187.43	30.81%	28.79%	0.91	801,000	-58.48%
HAE	HAEMONETICS CORP	$68.37	-0.65%	-2.47%	-14.84%	33.51%	-8.42%	-4.10%	-22.22%	-42.60%	118.02%	$87.32	$47.32	21.70%	44.48%	0.80	742,000	-22.47%
BAX	BAXTER INTERNATIONAL INC	$19.65	-0.96%	1.39%	1.39%	-15.19%	-31.10%	-41.27%	-57.43%	-75.68%	-46.22%	$37.74	$17.40	47.93%	12.93%	0.63	4,520,000	-39.03%
ICUI	ICU MEDICAL INC	$152.86	0.12%	-0.24%	3.37%	24.37%	19.89%	-11.27%	-18.32%	-29.15%	58.65%	$173.85	$107.00	12.07%	42.86%	0.98	267,000	16.09%
STVN	STEVANATO GROUP SPA	$17.28	0.06%	-9.53%	-16.52%	-33.49%	-33.46%	-18.26%	-15.71%	N/A	N/A	$28.00	$16.30	38.29%	6.01%	0.91	983,000	-62.47%
BDX	BECTON DICKINSON & CO	$203.42	0.81%	0.01%	3.61%	8.76%	11.19%	-18.21%	-18.35%	-21.26%	39.80%	$251.99	$162.29	19.27%	25.34%	0.47	972,000	-71.69%
RGEN	REPLIGEN CORP	$163.34	0.62%	0.01%	-1.73%	1.39%	36.51%	-2.78%	-15.39%	-19.13%	589.49%	$182.52	$102.97	10.51%	58.64%	1.45	497,000	-26.26%
BLFS	BIOLIFE SOLUTIONS INC	$24.94	0.28%	0.73%	0.16%	-11.06%	12.19%	-11.81%	4.79%	-37.00%	1,140.80%	$29.62	$19.10	15.80%	30.58%	1.86	215,000	-20.07%
LMAT	LEMAITRE VASCULAR INC	$85.28	1.26%	-0.61%	1.79%	-5.37%	3.41%	-13.91%	85.59%	79.16%	474.28%	$105.55	$71.42	19.20%	19.41%	0.80	73,000	-37.07%
ANGO	ANGIODYNAMICS INC	$10.33	-0.48%	-0.29%	-21.15%	-15.95%	13.27%	-15.47%	-20.54%	-45.14%	-9.47%	$13.99	$8.27	26.16%	24.91%	1.01	506,000	30.75%
RMD	RESMED INC	$255.47	1.22%	0.90%	4.38%	-1.44%	-6.59%	0.30%	10.04%	14.93%	332.85%	$293.81	$199.92	13.05%	27.79%	0.82	819,000	13.43%
ALC	ALCON INC	$80.79	0.62%	2.19%	0.51%	6.16%	-10.38%	-11.56%	7.82%	6.29%	N/A	$99.20	$71.55	18.56%	12.91%	0.82	548,000	-41.64%
PDEX	PRO DEX INC	$40.87	4.47%	-2.06%	3.60%	41.57%	-23.61%	-0.97%	134.89%	21.42%	1,669.26%	$70.26	$23.47	41.83%	74.14%	0.56	21,200	72.36%
COO	COOPER COMPANIES INC	$80.90	-0.48%	0.36%	-2.08%	11.05%	10.96%	-18.65%	-7.31%	-14.26%	151.03%	$99.79	$61.78	18.93%	30.96%	0.89	1,332,000	-8.70%
UTMD	UTAH MEDICAL PRODUCTS INC	$62.47	1.99%	1.88%	10.08%	5.47%	8.14%	-2.65%	-29.61%	-25.72%	12.15%	$65.56	$51.26	4.71%	21.87%	0.56	36,500	170.37%
TFX	TELEFLEX INC	$104.20	0.77%	3.85%	-15.12%	-21.39%	-9.83%	-43.26%	-56.77%	-72.78%	-24.05%	$184.58	$100.18	43.55%	4.01%	0.87	742,000	-10.71%
XRAY	DENTSPLY SIRONA INC	$12.72	-0.08%	5.56%	10.42%	-2.83%	-20.85%	-35.14%	-65.49%	-77.75%	-78.52%	$20.60	$9.85	38.24%	29.14%	0.91	3,049,000	-22.69%
WRBY	WARBY PARKER INC	$27.38	3.79%	2.20%	13.23%	27.35%	13.70%	7.04%	66.24%	N/A	N/A	$30.90	$13.63	11.39%	100.88%	1.91	2,328,000	16.63%
ATR	APTARGROUP INC	$126.35	0.28%	2.04%	2.52%	-1.89%	-20.38%	-20.26%	12.02%	-9.00%	79.25%	$164.28	$103.23	23.09%	22.40%	0.69	267,000	-37.91%
NNNN	ANBIO BIOTECHNOLOGY	$22.67	-24.73%	-26.42%	-32.33%	-5.23%	-55.40%	N/A	N/A	N/A	N/A	$55.65	$5.18	59.26%	337.64%	0.28	85,000	632.76%
SMTI	SANARA MEDTECH INC	$21.25	-2.30%	-2.39%	-12.26%	-30.33%	-15.10%	-42.08%	-49.09%	-47.40%	254.17%	$37.91	$18.90	43.95%	12.43%	1.22	68,400	-25.25%
MDLN	MEDLINE INC	$44.84	-2.52%	1.56%	1.61%	N/A	N/A	N/A	N/A	N/A	N/A	$46.64	$34.92	3.86%	28.41%	0.05	1,838,000	-1.66%
EKSO	EKSO BIONICS HOLDINGS INC	$7.92	-9.07%	-3.65%	42.45%	60.98%	74.83%	-15.79%	-69.66%	-94.39%	-99.44%	$12.70	$2.73	37.64%	190.11%	0.83	351,000	83.77%
LUCY	INNOVATIVE EYEWEAR INC	$1.34	-3.60%	5.51%	9.84%	-25.56%	-36.19%	-77.44%	-95.47%	N/A	N/A	$5.86	$0.95	77.14%	41.05%	1.00	188,000	5.62%
BNGO	BIONANO GENOMICS INC	$1.53	-5.56%	6.25%	0.66%	-19.90%	-53.21%	-73.71%	-99.86%	-99.98%	N/A	$6.32	$1.42	75.77%	8.13%	2.06	110,000	-44.16%
FEMY	FEMASYS INC	$0.60	-4.00%	-11.63%	-15.49%	-15.37%	-30.64%	-44.95%	-49.15%	N/A	N/A	$1.80	$0.31	66.67%	95.44%	0.55	481,000	-43.74%
PLSE	PULSE BIOSCIENCES INC	$14.32	-5.10%	3.54%	-0.56%	-18.17%	-5.85%	-23.26%	354.60%	-58.18%	N/A	$25.00	$12.56	42.72%	14.01%	1.38	169,000	-19.91%
STXS	STEREOTAXIS INC	$2.59	-3.00%	-1.89%	5.28%	-15.08%	0.00%	12.12%	19.35%	-45.36%	292.42%	$3.59	$1.54	27.86%	68.18%	1.16	275,000	-5.50%
STSS	SHARPS TECHNOLOGY INC	$2.13	-1.84%	-2.29%	-4.05%	-60.63%	-64.68%	-99.51%	-99.98%	N/A	N/A	$211.20	$1.65	98.99%	29.09%	0.64	1,090,000	128.51%
KMTS	KESTRA MEDICAL TECHNOLOGIES LTD	$24.82	0.89%	7.91%	-8.51%	-8.31%	50.42%	N/A	N/A	N/A	N/A	$30.00	$13.25	17.27%	87.32%	1.17	148,000	-14.45%
OSUR	ORASURE TECHNOLOGIES INC	$2.71	1.50%	4.63%	11.98%	-6.23%	-19.10%	-34.06%	-47.78%	-80.86%	-52.29%	$4.22	$2.08	35.78%	30.29%	1.07	407,000	-14.14%
MBOT	MICROBOT MEDICAL INC	$1.92	-3.03%	-7.69%	-10.70%	-19.67%	-33.79%	-4.00%	-39.43%	-78.78%	-99.64%	$4.67	$1.25	58.89%	53.60%	1.31	1,372,000	-7.36%
AVR	ANTERIS TECHNOLOGIES GLOBAL CORP	$6.29	-2.63%	9.39%	12.52%	20.27%	87.76%	4.83%	N/A	N/A	N/A	$8.79	$2.34	28.44%	168.80%	1.74	910,000	-39.77%
AGPU	AXE COMPUTE INC	$4.90	-11.07%	-18.20%	-31.94%	-47.31%	-59.17%	-76.50%	-96.15%	-98.77%	-100.00%	$39.00	$3.88	87.44%	26.29%	1.31	105,000	130.77%
ZJYL	JIN MEDICAL INTERNATIONAL LTD	$0.14	5.22%	6.82%	-36.77%	-54.81%	-78.67%	-82.15%	N/A	N/A	N/A	$1.03	$0.12	86.24%	22.61%	1.10	1,921,000	-19.86%
ZTEK	ZENTEK LTD	$0.78	-4.76%	-5.33%	11.57%	-11.25%	-19.40%	-31.49%	-47.23%	N/A	N/A	$1.84	$0.62	57.58%	25.97%	0.70	70,000	20.69%
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	$0.43	3.33%	-7.46%	-5.65%	-55.17%	-94.42%	N/A	N/A	N/A	N/A	$9.50	$0.38	95.43%	15.43%	0.65	100,000	11.11%
RGNT	REGENTIS BIOMATERIALS LTD	$6.88	-5.10%	-3.10%	3.46%	N/A	N/A	N/A	N/A	N/A	N/A	$8.35	$5.75	17.60%	19.65%	0.12	18,600	-15.45%
GCTK	GLUCOTRACK INC	$3.37	-6.91%	-11.32%	-19.76%	-49.25%	-50.80%	-96.93%	-99.96%	-99.28%	-99.94%	$133.80	$3.21	97.48%	4.98%	4.35	31,300	-47.83%
POCI	PRECISION OPTICS CORPORATION INC	$5.13	1.18%	16.06%	22.00%	21.56%	9.15%	2.60%	-15.98%	8.92%	242.00%	$5.34	$3.77	3.91%	36.22%	0.22	6,800	-68.52%
STAA	STAAR SURGICAL CO	$19.11	-0.16%	-8.87%	-18.16%	-31.21%	-0.73%	-22.29%	-72.67%	-81.71%	185.22%	$30.81	$13.50	37.97%	41.56%	1.44	1,318,000	7.50%
RVP	RETRACTABLE TECHNOLOGIES INC	$0.73	5.80%	1.11%	-12.36%	-21.00%	0.83%	-7.71%	-62.56%	-95.35%	-73.98%	$1.14	$0.62	35.96%	17.74%	0.85	108,000	94.59%
NYXH	NYXOAH SA	$4.79	2.13%	1.27%	7.16%	-9.45%	-33.19%	-55.77%	-13.07%	N/A	N/A	$11.87	$4.35	59.65%	10.24%	0.43	92,000	9.52%
NXGL	NEXGEL INC	$1.60	-4.19%	3.90%	4.58%	-37.98%	-29.82%	-50.92%	16.79%	N/A	N/A	$4.00	$1.45	60.00%	10.34%	0.82	59,600	133.73%
MLSS	MILESTONE SCIENTIFIC INC	$0.30	-2.30%	5.32%	2.41%	-35.43%	-39.01%	-77.67%	-57.27%	-89.76%	-83.68%	$1.35	$0.22	78.00%	36.24%	1.14	141,000	-43.15%
HOLX	HOLOGIC INC	$75.19	0.19%	0.11%	0.93%	1.68%	14.46%	3.35%	-9.33%	0.90%	106.34%	$75.34	$51.90	0.20%	44.87%	0.51	975,000	-51.80%

Medical Stocks FAQ

What are the best medical stocks to buy right now in Jan 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best medical stocks to buy right now are:

1. Nephros (NASDAQ:NEPH)

Nephros (NASDAQ:NEPH) is the #1 top medical stock out of 57 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Nephros (NASDAQ:NEPH) is: Value: C, Growth: C, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Nephros (NASDAQ:NEPH) has a Due Diligence Score of 53, which is 23 points higher than the medical industry average of 30.

NEPH passed 17 out of 33 due diligence checks and has strong fundamentals. Nephros has seen its stock return 172.12% over the past year, overperforming other medical stocks by 200 percentage points.

Nephros has an average 1 year price target of $6.00, an upside of 33.63% from Nephros's current stock price of $4.49.

Nephros stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Nephros, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Infusystem Holdings (NYSEMKT:INFU)

Infusystem Holdings (NYSEMKT:INFU) is the #2 top medical stock out of 57 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Infusystem Holdings (NYSEMKT:INFU) is: Value: C, Growth: C, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Infusystem Holdings (NYSEMKT:INFU) has a Due Diligence Score of 45, which is 15 points higher than the medical industry average of 30.

INFU passed 14 out of 33 due diligence checks and has strong fundamentals. Infusystem Holdings has seen its stock return 4.59% over the past year, overperforming other medical stocks by 32 percentage points.

Infusystem Holdings has an average 1 year price target of $14.50, an upside of 67.63% from Infusystem Holdings's current stock price of $8.65.

Infusystem Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Infusystem Holdings, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Envista Holdings (NYSE:NVST)

Envista Holdings (NYSE:NVST) is the #3 top medical stock out of 57 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Envista Holdings (NYSE:NVST) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: A, Financials: C, and AI: C.

Envista Holdings (NYSE:NVST) has a Due Diligence Score of 36, which is 6 points higher than the medical industry average of 30.

NVST passed 11 out of 33 due diligence checks and has average fundamentals. Envista Holdings has seen its stock return 11.34% over the past year, overperforming other medical stocks by 39 percentage points.

Envista Holdings has an average 1 year price target of $21.50, a downside of -10.6% from Envista Holdings's current stock price of $24.05.

Envista Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Envista Holdings, 25% have issued a Strong Buy rating, 0% have issued a Buy, 75% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical stocks with highest dividends?

Out of 10 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 5.59%, which is 3 percentage points higher than the medical industry average of 2.16%.

Embecta's dividend payout ratio of 36.6% indicates that its high dividend yield is sustainable for the long-term.

2. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 5.03%, which is 3 percentage points higher than the medical industry average of 2.16%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -14.6% indicates that its high dividend yield might not be sustainable for the long-term.

3. Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) has an annual dividend yield of 2.65%, which is the same as the medical industry average of 2.16%. Baxter International's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Baxter International's dividend has not shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of -103% indicates that its dividend yield might not be sustainable for the long-term.

Why are medical stocks up?

Medical stocks were up 0.33% in the last day, and down -0.31% over the last week.

We couldn't find a catalyst for why medical stocks are up.

What are the most undervalued medical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued medical stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued medical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 65 points higher than the medical industry average of 21. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -44.64% in the past year. It has underperformed other stocks in the medical industry by -17 percentage points.

2. Haemonetics (NYSE:HAE)

Haemonetics (NYSE:HAE) is the second most undervalued medical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Haemonetics has a valuation score of 43, which is 22 points higher than the medical industry average of 21. It passed 3 out of 7 valuation due diligence checks.

Haemonetics's stock has dropped -4.1% in the past year. It has overperformed other stocks in the medical industry by 24 percentage points.

3. Harvard Bioscience (NASDAQ:HBIO)

Harvard Bioscience (NASDAQ:HBIO) is the third most undervalued medical stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harvard Bioscience has a valuation score of 14, which is -7 points higher than the medical industry average of 21. It passed 1 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates HBIO a Valuation Rating of "B".

Harvard Bioscience's stock has dropped -68.06% in the past year. It has underperformed other stocks in the medical industry by -40 percentage points.

Are medical stocks a good buy now?

41.46% of medical stocks rated by analysts are a strong buy right now. On average, analysts expect medical stocks to rise by 20.16% over the next year.

11.11% of medical stocks have a Zen Rating of A (Strong Buy), 24.44% of medical stocks are rated B (Buy), 44.44% are rated C (Hold), 13.33% are rated D (Sell), and 6.67% are rated F (Strong Sell).

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is 228.45x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2026)
Top medical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Medical Stocks FAQ

1. Nephros (NASDAQ:NEPH)

2. Infusystem Holdings (NYSEMKT:INFU)

3. Envista Holdings (NYSE:NVST)

1. Embecta (NASDAQ:EMBC)

2. Dentsply Sirona (NASDAQ:XRAY)

3. Baxter International (NYSE:BAX)

1. Embecta (NASDAQ:EMBC)

2. Haemonetics (NYSE:HAE)

3. Harvard Bioscience (NASDAQ:HBIO)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareMedical Instruments & SuppliesBest Medical Stocks to Buy Now (2026)Top medical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Medical Stocks FAQ

1. Nephros (NASDAQ:NEPH)

2. Infusystem Holdings (NYSEMKT:INFU)

3. Envista Holdings (NYSE:NVST)

1. Embecta (NASDAQ:EMBC)

2. Dentsply Sirona (NASDAQ:XRAY)

3. Baxter International (NYSE:BAX)

1. Embecta (NASDAQ:EMBC)

2. Haemonetics (NYSE:HAE)

3. Harvard Bioscience (NASDAQ:HBIO)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2026)
Top medical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.